D-0380-2021 Class III Terminated

Recalled by SigmaPharm Laboratories LLC — Bensalem, PA

FDA drug recall D-0380-2021 was initiated by SigmaPharm Laboratories LLC on Apr 19, 2021 and is designated Class III. Reason for recall: Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent The recall status is terminated (terminated Sep 26, 2022). Affected quantity: 8786 bottles.

Recall details

Product Type
Drugs
Report Date
May 26, 2021
Initiation Date
Apr 19, 2021
Termination Date
Sep 26, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8786 bottles

Product description

Asenapine Sublingual Tablets, 10 mg, Rx only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020, NDC 42794-017-10

Reason for recall

Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

Distribution pattern

Nationwide in the US

Code information

Lots # 2012801, 2012901, 2013001 & Lot 2100501, Exp AUG 2022; 2100101, Exp NOV 2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0380-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0380-2021. Report a data issue: hello@regdatalab.com.